康方生物（09926）今日盘中大跌8.95%，引发市场关注。该股在早盘交易时段出现显著下跌，反映出投资者对生物医药板块的谨慎态度。
从整体市场来看，港股生物医药板块在开盘时集体走低，显示出该行业面临普遍压力。康方生物作为板块内的重要成员，其股价表现也受到了行业整体趋势的影响。
除康方生物外，其他生物医药股也出现不同程度的下跌。MIRXES-B（02629）跌幅超过5%，云顶新耀（01952）和映恩生物-B（09606）均下跌超过4%。这种普遍性的下跌趋势表明，投资者可能正在重新评估生物医药行业的短期风险和增长前景。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.